Other OTC Pharmaceuticals - Malaysia

Malaysia

Highlights

In Malaysia, the revenue generated in the Other OTC Pharmaceuticals market in 2024 amounts to US$330.40m.
It is projected that this market will experience an annual growth rate of 2.20% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, reaching US$7.17bn in 2024.
On a per person basis, the revenue generated in Malaysia amounts to US$9.53 in 2024.
In Malaysia, the market for Other OTC Pharmaceuticals is experiencing a surge in demand due to the growing awareness of self-medication and the increasing availability of these products in pharmacies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Malaysia is experiencing steady growth due to several key factors.

Customer preferences: Customers in Malaysia are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This can be attributed to a number of factors, including convenience, affordability, and the growing trend of self-medication. OTC pharmaceuticals offer consumers the ability to treat common ailments and minor health issues without the need for a prescription or a visit to the doctor. This allows individuals to take control of their own health and well-being, and provides them with a sense of empowerment.

Trends in the market: One of the major trends in the Other OTC Pharmaceuticals market in Malaysia is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use, and are seeking out natural alternatives to traditional pharmaceuticals. This trend is driven by a desire for products that are perceived as safer and more gentle on the body. As a result, there has been a surge in the availability and popularity of herbal supplements, traditional medicines, and homeopathic remedies.Another trend in the market is the growing popularity of online purchasing. With the rise of e-commerce platforms and the increasing use of smartphones, consumers in Malaysia are turning to online channels to purchase their OTC pharmaceuticals. This allows for greater convenience and accessibility, as customers can browse and purchase products from the comfort of their own homes. Online platforms also offer a wider range of products and competitive pricing, making it an attractive option for consumers.

Local special circumstances: One of the unique aspects of the Malaysian market is the cultural diversity and traditional medicine practices. Traditional medicine, such as traditional Chinese medicine and Malay traditional medicine, has a long history in Malaysia and continues to be widely practiced. This has created a niche market for traditional remedies and herbal supplements, which are sought after by consumers who place value on traditional healing methods. The presence of traditional medicine alongside modern pharmaceuticals adds to the diversity of the OTC market in Malaysia.

Underlying macroeconomic factors: The growing middle class and increasing disposable income in Malaysia are contributing to the growth of the Other OTC Pharmaceuticals market. As individuals have more disposable income, they are willing to spend more on healthcare products, including OTC pharmaceuticals. The rising middle class is also driving demand for higher quality and more premium products, leading to a shift towards branded and higher-priced OTC pharmaceuticals.In conclusion, the Other OTC Pharmaceuticals market in Malaysia is experiencing growth due to customer preferences for convenience, affordability, and self-medication. The market is also influenced by trends such as the demand for natural and herbal remedies, as well as the popularity of online purchasing. The presence of traditional medicine and the growing middle class are additional factors contributing to the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.